AI Model Differentiates Scalp Psoriasis From Seborrheic Dermatitis

THURSDAY, Feb. 16, 2023 (HealthDay News) -- A deep learning (DL) model based on dermatoscopic images can differentiate scalp psoriasis from seborrheic dermatitis, according to a study recently published in Frontiers in Medicine.
Zhang Yu, from Inner Mongolia Medical University in Hohhot, China, and colleagues developed a new diagnostic method for discriminating scalp psoriasis and seborrheic dermatitis based on a DL model. A total of 1,358 pictures from 617 patients with pathological and diagnostic confirmed skin diseases (508 cases of psoriasis; 850 cases of seborrheic dermatitis) were randomly allocated into training, validation, and testing datasets (1,088, 134, and 136, respectively). The transfer learning technique was used to establish and train a DL model for differentiating the two diseases.
The researchers found that the DL model exhibited good sensitivity and specificity (96.1 and 88.2 percent), with an area under the curve (AUC) of 0.922. Compared with five dermatologists with various levels of experience, the DL model outperformed them for diagnosis of scalp psoriasis and seborrheic dermatitis. Comparable diagnostic performance can be achieved for nonproficient doctors with the assistance of the DL model and dermatologists proficient in dermoscopy. Diagnostic performance was improved for one dermatology graduate student and two general practitioners, with the AUC values increasing from 0.600, 0.537, and 0.575 to 0.849, 0.778, and 0.788, respectively; consistency of diagnosis was also improved with the kappa values increasing from 0.191, 0.071, and 0.143 to 0.679, 0.550, and 0.568, respectively.
"The DL model can prevent the delay of patients' treatment, tackle the development of the disease course, and improve the prognosis when encountering patients with ambiguous diagnoses," the authors write.
Related Posts
When Cities Get a Pro Sports Team, Flu Deaths Rise
TUESDAY, Aug. 8, 2023 (HealthDay News) -- Bringing a professional sports team to...
La mayoría de pacientes de Alzheimer no habrían calificado para el ensayo de controversial fármaco: estudio
MARTES, 14 de septiembre de 2021 (HealthDay News) -- La aprobación en EE. UU. de...
High Costs Seen for Nonoperative Therapy for Late-Stage Knee Arthritis Prior to TKA
WEDNESDAY, Oct. 5, 2022 (HealthDay News) -- Patients with late-stage knee...
Las temperaturas altas y el esmog intenso son una combinación letal, según un estudio
MARTES, 5 de julio de 2022 (HealthDay News) -- El calor, en conjunto con el...
